Pain is seen by many as the so-called fifth vital sign but is it reasonable to expect us to eliminate it entirely? The long term consequences for medicine and our patients are now manifesting in daily newscasts regarding "the opioid epidemic".

Presented by Monty Mythen with Dr Patrick Shanahan, Anesthesiology Consultants Enterprises, Louisville KY and Mike Grocott, Professor of Anaesthesia and Critical Care Medicine, University of Southampton.

Pain is seen by many as the so-called fifth vital sign but is it reasonable to expect us to eliminate it entirely? The long term consequences for medicine and our patients are now manifesting in daily newscasts regarding "the opioid epidemic".

Presented by Monty Mythen with Dr Patrick Shanahan, Anesthesiology Consultants Enterprises, Louisville KY and Mike Grocott, Professor of Anaesthesia and Critical Care Medicine, University of Southampton.

The EBPOM-USA Dallas Masters Course, held between the 22nd - 24th of March 2019, has provided TopMedTalk with a wealth of exciting new material which we will be sharing with you over the next few months. Here you can reflect on the conference or, if you didn't manage to attend, whet your appitite for what is to come. Presented by Desiree Chappell with Monty Mythen, Sol Aronson and Vicki Morton.

The EBPOM-USA Dallas Masters Course, held between the 22nd - 24th of March 2019, has provided TopMedTalk with a wealth of exciting new material which we will be sharing with you over the next few months. Here you can reflect on the conference or, if you didn't manage to attend, whet your appitite for what is to come.   Presented by Desiree Chappell with Monty Mythen, Sol Aronson and Vicki Morton.

Here we feature a central figure in the ongoing Great World Fluid debate. He was sadly unable to attend EBPOM 2018 so we wanted to get a very important contribution from him: What are the big takeaways from some of the larger trials such as Saline versus Albumin Fluid Evaluation (SAFE)? What about the long term implications of Crystalloid versus Hydroxyethyl Starch Trial (CHEST)? What new trials should be on the horizon - given the information we now have? Monty Mythen speaks with his guest Professor John A Myburgh, Intensive Care Medicine, University of New South Wales; Director of the Division of Critical Care and Trauma at the George Institute for Global Health and Senior Intensive Care Physician at the St George Hospital, Sydney. He holds honorary Professorial appointments at the University of Sydney and Monash University School of Public Health and Preventive Medicine.

Here we feature a central figure in the ongoing Great World Fluid debate. He was sadly unable to attend EBPOM 2018 so we wanted to get a very important contribution from him: What are the big takeaways from some of the larger trials such as Saline versus Albumin Fluid Evaluation (SAFE)? What about the long term implications of Crystalloid versus Hydroxyethyl Starch Trial (CHEST)? What new trials should be on the horizon - given the information we now have?   Monty Mythen speaks with his guest Professor John A Myburgh, Intensive Care Medicine, University of New South Wales; Director of the Division of Critical Care and Trauma at the George Institute for Global Health and Senior Intensive Care Physician at the St George Hospital, Sydney.   He holds honorary Professorial appointments at the University of Sydney and Monash University School of Public Health and Preventive Medicine.

What's the relationship between Enhanced Recovery after Surgery (ERAS) and Prehabilitation? Should prehabilitation be thought of as a natural part of perioperative enhancement? Should practitioners learn to think of exercise as an anabolic stimulant? Mike Grocott presents with his guests Olle Ljungqvist, Prof. of Surgery, MD, PhD, Surgeon, Örebro University Hospital & Karolinska Institutet, Sweden and Franco Carli, Prof. MD, PhD, Anesthesiologist, McGill University, Canada.

What's the relationship between Enhanced Recovery after Surgery (ERAS) and Prehabilitation? Should prehabilitation be thought of as a natural part of perioperative enhancement? Should practitioners learn to think of exercise as an anabolic stimulant?   Mike Grocott presents with his guests Olle Ljungqvist, Prof. of Surgery, MD, PhD, Surgeon, Örebro University Hospital & Karolinska Institutet, Sweden and Franco Carli, Prof. MD, PhD, Anesthesiologist, McGill University, Canada.

How has perioperative medicine impacted upon our understanding of obstetrics? Hear how implimenting an ERAS programme in 2016 has benefitted the pioneers who led the way here. Is it something you could impliment in your practice? Presented by Robin Schiller and Bridger Bach with their guests Dr Attila Kett, anaesthesiologist and Chairman at St Peter's University Hospital at New Jersey and Dr Elizabeth Cherot, Vice President of medical affairs at Axia Women's Health.

How has perioperative medicine impacted upon our understanding of obstetrics? Hear how implimenting an ERAS programme in 2016 has benefitted the pioneers who led the way here. Is it something you could impliment in your practice?   Presented by Robin Schiller and Bridger Bach with their guests Dr Attila Kett, anaesthesiologist and Chairman at St Peter’s University Hospital at New Jersey and  Dr Elizabeth Cherot, Vice President of medical affairs at Axia Women’s Health.